Zelira Therapeutics Limited (ZLDAF)
OTCMKTS · Delayed Price · Currency is USD
0.2792
+0.0583 (26.39%)
At close: Jun 4, 2025

Zelira Therapeutics Revenue

Zelira Therapeutics had revenue of 655.00 AUD in the half year ending December 31, 2024, a decrease of -99.15%. This brings the company's revenue in the last twelve months to 40.88K, down -85.34% year-over-year. In the fiscal year ending June 30, 2024, Zelira Therapeutics had annual revenue of 94.95K, down -68.47%.

Revenue (ttm)
40.88K AUD
Revenue Growth
-85.34%
P/S Ratio
129.83
Revenue / Employee
n/a
Employees
n/a
Market Cap
3.28M USD

Revenue Chart

* This company reports financials in AUD.

Revenue History

Fiscal Year End Revenue Change Growth
Jun 30, 2024 94.95K -206.17K -68.47%
Jun 30, 2023 301.12K -1.24M -80.45%
Jun 30, 2022 1.54M 877.31K 132.26%
Jun 30, 2021 663.32K - -
Jun 30, 2020 - - -
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro
Jun 30, 2016 Pro Pro Pro